Characterizing circulating biomarkers for childhood dementia disorders: A scoping review of clinical trials
Childhood dementias, a group of neurological disorders are characterised by neurocognitive decline, with physical and psychosocial impacts for individuals. With therapy available for <5 % of childhood dementias, there is a high level of unmet need. Integration of biomarkers in clinical trials ar...
Saved in:
| Main Authors: | Arlene D'Silva, James Barnes, Jason Djafar, Kaustuv Bhattacharya, Jingya Yan, Shekeeb Mohammad, Sushil Bandodkar, Alexandra Johnson, Michel Tchan, Christina Miteff, Kristina L. Elvidge, Russell C. Dale, Michelle Farrar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Neurotherapeutics |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747925000248 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endpoints: types, selection, interpretation of the results obtained on the example of cardiology studies
by: A. R. Navasardyan, et al.
Published: (2022-06-01) -
Rehabilitation of COVID-19 convalescents and its impact on cardiovascular endpoints: propensity score matching analysis
by: G. Kh. Lasynova, et al.
Published: (2023-12-01) -
Integrated Analysis of Metabolites and Biological Endpoints Bring New Insights into Sulfamethoxazole Stress Tolerance in Ryegrass
by: Yong Yang, et al.
Published: (2025-02-01) -
Frontotemporal dementia: peculiarities of clinical variants
by: B. Klimbytė, et al.
Published: (2021-12-01) -
Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials
by: Jeffrey C. Yu, et al.
Published: (2022-01-01)